Maraviroc may work as PrEP in combination with another drug – but probably not by itself
Expanding treatment and PrEP could prevent 185,000 new HIV infections, US CDC says
Modest kidney function decline in people taking Truvada for PrEP supports need for monitoring
Rate of entry into HIV care improved by personalised counselling
Studies probe retention in HIV care for women who start antiretroviral treatment during pregnancy
Experimental TLR7 agonist suppresses HIV-like virus in monkeys after ART interruption
Study does not support routine HPV quadrivalent vaccination to protect against anal cancer in older people living with HIV
‘On-demand’ rectal microbicide gel has reasonable tolerability and acceptability – daily less so
Life expectancy in HIV-positive people in the US still lags 13 years behind HIV-negative people
Option B+ has enabled Malawi to make significant progress towards 90-90-90
Condom use in French PrEP trial: half only used PrEP, a quarter used condoms and PrEP, one in six used neither
Empirical TB treatment comes up short again
Sofosbuvir/ledipasvir for 6 weeks cures HCV in HIV-positive people with acute HCV if viral load is low
Large-scale household TB screening shows feasibility in PopART trial
Almost-certain case of PrEP failure due to drug resistance reported at CROI 2016
Early antiretroviral therapy reduces the risk of infection-related cancers
HIV in the brain: new tools and treatment to keep your mind beautiful
Removing clinic barriers to rapid initiation of ART in Uganda enables 70% to start on the same day
